Jon Jones Eligible To Return July 2017 After Failed UFC 200 Drug Test

Written by Tom Ngo
December 15th, 2016

UFC Jon Jones

Jon Jones (pictured) can officially put his UFC 200 debacle behind him. During Thursday’s Nevada Athletic Commission hearing, Jones agreed to a one-year suspension after flunking June 16’s out-of-competition drug test for hydroxyclomiphene and Letrozale.

Both anti-estrogen drugs are banned year-round. Jones denied any wrongdoing from from the jump.

Today was a best-case scenario for Jones, as the NAC’s punishment matches the exact terms that was dished out by the USADA (United States Anti-Doping Agency) following November’s arbitration hearing with the former UFC light heavyweight champion.

During that meeting, Jones revealed he consumed a contaminated sexual enhancement pill he received from teammate Eric Blasic that he believed to be Cialis. Jones later discovered the “d*ck pill” was not Cialis, but a similar form of Tadalafil that Blasich purchased from AllAmericanPeptide.com. The USADA ordered and tested the same Tadalafil pill from AllAmericanPetptide.com and discovered it was contaminated with the same banned substances Jones was popped for.

The independent three-person arbitration panel from McLaren Global Sports Solutions, Inc. acknowledged that Jones is “not a drug cheat,” but extremely “reckless” in consuming a random pill before confirming exactly what he put in his body.

The UFC subsequently stripped Jones of his interim light heavyweight belt following the USADA’s 12-month ban.

Jones was slated to face light heavyweight champion Daniel Cormier in a title unification bout in UFC 200’s featured attraction before getting yanked from the bout just three days before showtime due to his positive drug test. It is believed Jones lost out on roughly $9-$10 million by getting pulled from the historic event.

Jones will be eligible to return to action on July 6, 2017.

Don’t forget to follow @5thRound on Twitter, Facebook and Google+!